New Position Statement Focuses on Patient Experience in Diabetes Care
Endocrine News
by Mark Newman
1d ago
Healthcare providers who treat diabetes need to think beyond the clinical numbers, such as solely focusing on a person’s glucose goals. Taking the patient experience into account can improve the quality of care and facilitate attainment of treatment goals, according to a new position statement published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.  The position statement reflects the consensus of two virtual roundtables the Endocrine Society held in 2022. Participants included representatives from the American College of Cardiology, American College of Ph ..read more
Visit website
How Cancer Affects Childhood Growth
Endocrine News
by Derek Bagley
1d ago
Childhood cancer patients and survivors are at increased risk for growth disturbances, for myriad reasons, and it is important to periodically monitor their growth, according to a paper recently published in The Journal of Clinical Endocrinology & Metabolism. Tomoko Yoshida, MD, PhD, and Angela Delaney, MD, both of St. Jude Children’s Research Hospital in Memphis, Tenn., point out that the chance of curing cancer in children and adolescents is dramatically increasing, as treatments and supportive care continue to improve. But with this increase comes awareness of complications among surviv ..read more
Visit website
Pharma Fridays – February 16, 2024
Endocrine News
by Mark Newman
5d ago
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Medicare Coverage Significantly Expanded for the Eversense E3 CGM System On February 12, Ascensia Diabetes Care, announced that Medicare has significantly expanded access to the Eversense E3 CGM System with the implementation of Local Coverage Determinations providing access to implantable CGM for basal only patients, by the first three Medicare Administrative Contractors (MACs). Ascensia Diabetes Care is a global diabetes care company, and Senseonics Holdings, Inc., a medical technology comp ..read more
Visit website
Word of Honour: John William Honour, PhD, FRCPATH, Discusses His Recent Book on Steroids
Endocrine News
by Derek Bagley
1w ago
An Endocrine Society member since 1979, John William Honour, PhD, FRCPath, used his time in lockdown to write a voluminous tome on steroids. He talks to Endocrine News about his recent book, Steroids in the Laboratory and Clinical Practice, how it was impacted by the COVID-19 pandemic, and why it may just be the definitive book for endocrine researchers and clinicians alike. Last year, John William Honour, PhD, FRCPath, a retired consultant clinical scientist at University College London Hospitals in the U.K. with more than 45 years of laboratory work in steroid endocrinology, published Steroi ..read more
Visit website
Staying Curious: How Felix Beuschlein, MD, Has Advanced Adrenal Tumor Care Through Transatlantic Collaboration 
Endocrine News
by Derek Bagley
1w ago
Honored by both the Endocrine Society and the European Society of Endocrinology with the 2024 Transatlantic Alliance Award, Felix Beuschlein, MD, has made significant contributions to endocrine research on both sides of the Atlantic, from Michigan to Switzerland! Endocrine News speaks with Beuschlein about what this award means to him, conducting pioneering research on two different continents, and why he became an endocrinologist in the first place. In October, the Endocrine Society and the European Society of Endocrinology (ESE) jointly awarded the 2024 Transatlantic Alliance Award to Prof ..read more
Visit website
Pharma Friday – February 9
Endocrine News
by Mark Newman
1w ago
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia Last month, Spruce Biosciences, announced completion of enrollment in its CAHmelia-204 clinical trial of tildacerfont for the treatment of adult classic congenital adrenal hyperplasia (CAH). Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. “Completi ..read more
Visit website
Introducing EndoForum, the Endocrine Society’s Rebranded Online Community
Endocrine News
by Mark Newman
1w ago
After initially launching in 2022 and growing into a thriving community in 2023, the Endocrine Society’s online community in DocMatter is ready to step out into the spotlight with a brand-new name: EndoForum!  Why change the name? EndoForum is more than just the platform it’s on; it is a vibrant and active community of more than 16,000 Endocrine Society members from all walks of life, with interests and experiences that span the entirety of the endocrinology world, both literally and figuratively.  In EndoForum, members share challenging cases and new researc ..read more
Visit website
Endocrine Society Journals Remain Premiere Venue for Publishing Endocrine Research
Endocrine News
by Mark Newman
2w ago
Year after year, I am continually impressed with the quality and quantity of research that is published in the Society’s suite of scientific journals. As the former co-editor-in-chief, with Andrea Gore, of the Society’s basic science flagship journal Endocrinology, and editor-in-chief of the Society’s other previous basic science journal, Molecular Endocrinology, I was privileged to help innumerable scientists from around the world bring their research to light for the benefit of our field, and ultimately, the patients and public we serve. The continued popularity of our journals can be seen i ..read more
Visit website
Aftershocks: Practicing Endocrinology Amid a Catastrophe
Endocrine News
by Derek Bagley
2w ago
Kemal Agbaht, MD, is a clinician at Iskenderun Gelisim Hospital in Hatay, Turkey, where he treats a wide spectrum of endocrine disorders. He’s on the editorial board of The Journal of Clinical Endocrinology & Metabolism; he’s a husband and father. But when an earthquake literally rocks your world, your priorities must shift with the tectonic plates. Today, February 6, marks one year since a devasting earthquake struck at the heart of Turkey, killing tens of thousands. Amidst the rubble and destruction, Endocrine Society member Kemal Agbaht, MD, persevered and continued to practice medicine ..read more
Visit website
Mount Sinai Researchers Find Testosterone Hormone Therapy for Transmasculine Individuals Is Safer Than Previously Thought
Endocrine News
by Derek Bagley
2w ago
A common concern about gender-affirming hormone therapy for transmasculine people is the risk of red blood cell volume changes and erythrocytosis with the use of prescribed testosterone. However, Mount Sinai researchers have found that testosterone treatment may be safer than previously reported, with results published recently in The Journal of Clinical Endocrinology and Metabolism. Mount Sinai researchers from the Division of Endocrinology and Center for Transgender Medicine and Surgery examined the relationship between the use of testosterone as part of gender-affirming hormone therapy (GAH ..read more
Visit website

Follow Endocrine News on FeedSpot

Continue with Google
Continue with Apple
OR